Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

By F. Chan, J. Ching, L. C. Hung, Vincent Wai-Sun Wong, V. Leung, N. Kung, A. Hui, Justin C.Y. Wu, W. Leung, V. Lee and 7 more. New England Journal of Medicine, 2005

601 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Gastroenterology, Hematology

View Paper: https://www.semanticscholar.org/paper/43a7882f45d91c272211d8a29611b6c8d24a00cc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Jose Luis Zamorano
2. K. Thygesen

Citations in the corpus

• [Guidelines on the management of stable angina pectoris: executive summary]. (2006, background): “A recent study showed that the addition of esomeprazole to aspirin (80 mg/day) was better than switching to clopidogrel for the prevention of recurrent ulcer bleeding in patients with ulcers and vascular disease.(152)”
• The management of antithrombotic agents for patients undergoing GI endoscopy. (2016, background): “For patients who develop ASA-related peptic ulcer disease bleeding, resumption of ASA with concurrent proton pump inhibitor therapy is superior to switching to clopidogrel alone for the preventionof recurrentGI bleeding.(88,89) The importanceof prompt resumption of cardiac aspirin is critical as dem”